These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 20001967)
1. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967 [TBL] [Abstract][Full Text] [Related]
2. Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer. Jiang Z; Xu Y; Cai S Hum Pathol; 2011 Mar; 42(3):361-8. PubMed ID: 21111449 [TBL] [Abstract][Full Text] [Related]
3. CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Jiang Z; Xu Y; Cai S Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051 [TBL] [Abstract][Full Text] [Related]
4. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma. Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of BMP7 in human colorectal cancer. Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
11. [Expression of HSP27 in colorectal carcinoma and its relationship with lymphatic metastasis]. Zhao L; Li ZG; Ding YQ Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):41-4. PubMed ID: 18227023 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of UNC5B expression in colorectal cancer. Okazaki S; Ishikawa T; Iida S; Ishiguro M; Kobayashi H; Higuchi T; Enomoto M; Mogushi K; Mizushima H; Tanaka H; Uetake H; Sugihara K Int J Oncol; 2012 Jan; 40(1):209-16. PubMed ID: 21922135 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients. Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977 [TBL] [Abstract][Full Text] [Related]
15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102 [TBL] [Abstract][Full Text] [Related]
17. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592 [TBL] [Abstract][Full Text] [Related]
18. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Takeuchi H; Bilchik A; Saha S; Turner R; Wiese D; Tanaka M; Kuo C; Wang HJ; Hoon DS Clin Cancer Res; 2003 Apr; 9(4):1480-8. PubMed ID: 12684423 [TBL] [Abstract][Full Text] [Related]
19. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis. Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632 [TBL] [Abstract][Full Text] [Related]
20. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer. Li C; Cai S; Wang X; Jiang Z PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]